NYSE · traded in Congress
Novo Nordisk A/S NVO
$38.6487 +0.0287 (+0.07%) Sep 25, 2026 5:14 AM ET
Market value$171.1B
P/E ratio-
Analyst target$46.00
52-week range-
Avg volume1,065,214
Dividend yield-
Chart
Congress trades in NVO
Members of Congress disclosed 1 transaction in NVO in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 08/26/2026 | Scott Franklin FL18 | Purchase | $1,001 - $15,000 | 9/17/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Our coverage
- No, the Treasury is not printing money to buy its own debt Fed & Rates · September 24, 2026
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.